http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
운동유발성 아나필락시스 환자에서 혈 중 tryptase 측정 1례
예영민,임선교,서유진,최정희,서창희,남동호,박해심 대한천식 및 알레르기학회 2004 천식 및 알레르기 Vol.24 No.1
Exercise-induced anaphylaxis(EIA) is a medical emergency in that it derives from a physical allergy. We reported a case of food-independent EIA based on history and laboratory data. A 40-year-old male patient was presented with generalized urticaria, angioedema, and syncope after jogging. He had suffered from allergic rhinitis for 25 years. Increased level of serum tryptase was noted. Mast cell activation might be suggested in the pathophysiologic mechanism of EIA. (J Asthma Allergy Clin Immunol 24 : 152-5, 2004)
Lim, Sun Gyo,Hur, Hoon,Han, Sang-Uk,Lee, Kee Myung,Kang, Joon Koo,Shin, Sung Jae,Cho, Yong Kwan,Kim, Jin Hong Informa UK (TaylorFrancis) 2017 Scandinavian journal of gastroenterology Vol.52 No.3
<P>Conclusions: LAEFTR currently seems to be the ideal treatment modality of intraluminal gastric SETs where their resection margins are difficult to define under laparoscopic guidance alone.</P>
( Sun Gyo Lim ),( Kwang Jae Lee ),( Kwang Wook Suh ),( Seung Yeop Oh ),( Soon Sun Kim ),( Jun Hwan Yoo ),( Jeong Ook Wi ) The Editorial Office of Gut and Liver 2013 Gut and Liver Vol.7 No.3
Background/Aims: In patients with occlusive colorectal cancers, a complete preoperative evaluation of the colon proximal to the obstruction is often impossible. We aimed to evaluate the feasibility of preoperative colonoscopy after stent placement and to determine whether the success rate of colonoscopy differs between covered and uncovered stents. Methods: Seventy-three patients with malignant colorectal obstruction were enrolled prospectively. In patients with a resectable cancer, a preoperative colonoscopy was performed after insertion of a self-expandable metal stent (SEMS). The success rate of complete preoperative colonoscopy was compared between covered and uncovered stents. Results: Forty-five of 73 patients who underwent stent placement had a resectable cancer (61.6%). A complete preoperative colonoscopy was possible in 40 of 45 patients (88.9%). The success rate of complete preoperative colonoscopy was significantly lower in the covered-stent group when the obstructing mass lesion was located in the sigmoid colon (p=0.024). Synchronous cancer was detected in one patient (2.2%). Stent migration was observed in four patients with a covered stent. Conclusions: A preoperative complete colonoscopy after SEMS placement was feasible and safe in most patients with malignant colorectal obstruction. Uncovered stents seem to have more advantages than covered stents in preoperative colonoscopy proximal to the obstruction. (Gut Liver 2013; 7:311-316)
The development of robotic flexible endoscopic platforms
Sun Gyo Lim 소화기인터벤션의학회 2020 International journal of gastrointestinal interven Vol.9 No.1
Many different types of endoscopy robot have been developed or are under development. Some of these innovative biotechnologies are dedicated to complex endoscopic procedures such as endoscopic submucosal dissection whereas others are purely diagnostic. In endoscopy robotics, there are still several problems that need a solution. These problems basically concern robotic locomotion and instrument control, as well as clinical application. Flexible robotic endoscopic platforms are divided into four categories as follows: robot-assisted flexible endoscopy for maneuvering, robotic flexible endoscopy with therapeutic functions, active flexible colonoscopy, and active capsule endoscope. A thorough literature analysis was performed to assess the current status of robotic flexible endoscopic platforms designed for advanced endoluminal procedures.
The development of robotic flexible endoscopic platforms
Sun Gyo Lim 소화기인터벤션의학회 2020 Gastrointestinal Intervention Vol.9 No.1
Many different types of endoscopy robot have been developed or are under development. Some of these innovative biotechnologies are dedicated to complex endoscopic procedures such as endoscopic submucosal dissection whereas others are purely diagnostic. In endoscopy robotics, there are still several problems that need a solution. These problems basically concern robotic locomotion and instrument control, as well as clinical application. Flexible robotic endoscopic platforms are divided into four categories as follows: robot-assisted flexible endoscopy for maneuvering, robotic flexible endoscopy with therapeutic functions, active flexible colonoscopy, and active capsule endoscope. A thorough literature analysis was performed to assess the current status of robotic flexible endoscopic platforms designed for advanced endoluminal procedures.
( Soon Sun Kim ),( Hyun Ji Kim ),( Dae Ryong Kang ),( Jin Hong Kim ),( Min-jae Yang ),( Sun Gyo Lim ),( Hyo Jung Cho ),( Jong Ik Park ),( Sun Hyuk Hwang ),( Jae Youn Cheong ),( Sung Won Cho ) 대한간학회 2017 춘·추계 학술대회 (KASL) Vol.2017 No.1
Aims: To evaluate and compare the long-term clinical outcomes in non-obese subjects with nonalcoholic fatty liver disease (NAFLD) and non-obese individuals with metabolic syndrome. Methods: A total of 2,920 participants were retrospectively selected from health check-up center in 2000 and were followed through December 2010. NAFLD was diagnosed using ultrasonography. Study subjects were stratified according to body mass index, NAFLD, and metabolic syndrome status. Results: The prevalence of non-obese subjects without NAFLD, non-obese subjects with NAFLD, obese subjects without NAFLD, and obese subjects with NAFLD was 58.2%, 14.4%, 10.2%, and 17.2%, respectively. The prevalence of metabolically healthy non-obese subjects, metabolically unhealthy non-obese subjects, metabolically healthy obese subjects, and metabolically unhealthy obese subjects was 63.9%, 8.7%, 14.0%, and 13.4%, respectively. In the multivariate analysis, non-obese subjects with NAFLD had a significantly higher risk for diabetes mellitus (DM) compared with non-obese subjects without NAFLD (HR 2.69, 95% CI 1.72-4.20, P<0.001); they did not have a significantly higher risk for hypertension or cardiovascular disease. Metabolically unhealthy non-obese subjects had a significantly higher risk for hypertension (HR 2.75, 95% CI 2.02- 3.74, P<0.001), DM (HR 5.72, 95% CI 3.68-8.89, P<0.001), and cardiovascular disease (HR 2.93, 95% CI 1.53-5.63, P=0.001). In a subgroup analysis with non-obese subjects, non-obese subjects with NAFLD, even without metabolic syndrome, had a higher risk for DM compared to control (HR 3.60, 95% CI 2.03-6.39, P<0.001). Conclusions: Non-obese subjects with NAFLD are at a higher risk for DM independent of whether they have metabolic syndrome.